deltatrials
Unknown PHASE4 INTERVENTIONAL 2-arm NCT02138981

Hepatectomy Versus Chemoembolization for Resectable Hepatocellular Carcinoma Beyond Milan Criteria

Hepatic Resection Versus Transarterial Chemoembolization as the Initial Treatment for Resectable Hepatocellular Carcinoma Beyond Milan Criteria

Sponsor: Dongguan Shi People's Hospital

Conditions Resectable Hepatocellular Carcinoma Beyond Milan Criteria
Interventions Chemoembolization and Response-Dependent Resection Immediate Resection
Updated 7 times since 2017 Last updated: Jul 31, 2018 Started: May 1, 2014 Primary completion: Aug 31, 2020 Completion: Aug 31, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02138981, this PHASE4 trial focuses on Resectable Hepatocellular Carcinoma Beyond Milan Criteria and remains ongoing. Sponsored by Dongguan Shi People's Hospital, it has been updated 7 times since 2014, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotRecruiting~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshotRecruiting~Sep 2018 – ~Sep 2020 · 24 months · monthly snapshotRecruiting~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 23 months · monthly snapshotUnknown

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE4

    Status: Unknown Status → Unknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE4

  4. Sep 2020 — Jan 2021 [monthly]

    Unknown Status PHASE4

    Status: Recruiting → Unknown Status

  5. Sep 2018 — Sep 2020 [monthly]

    Recruiting PHASE4

▶ Show 2 earlier versions

  1. Jun 2018 — Sep 2018 [monthly]

    Recruiting PHASE4

  2. Jan 2017 — Jun 2018 [monthly]

    Recruiting PHASE4

    First recorded

May 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Dongguan Shi People's Hospital
  • First Affiliated Hospital, Sun Yat-Sen University
  • First People's Hospital of Chenzhou
  • Kaiping Central Hospital
  • Sun Yat-sen University
  • Third Affiliated Hospital, Sun Yat-Sen University
Data source: Sun Yat-sen University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations